These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 19903843

  • 21. Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro.
    Gauthaman K, Yee FC, Cheyyatraivendran S, Biswas A, Choolani M, Bongso A.
    J Cell Biochem; 2012 Jun; 113(6):2027-39. PubMed ID: 22275115
    [Abstract] [Full Text] [Related]

  • 22. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q, Liu G, Shao D, Wang J, Yuan H, Chen T, Zhai R, Ni W, Tai G.
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [Abstract] [Full Text] [Related]

  • 23. The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma [corrected] cells.
    Cheng P, Ni Z, Dai X, Wang B, Ding W, Rae Smith A, Xu L, Wu D, He F, Lian J.
    Cell Death Dis; 2013 Feb 07; 4(2):e489. PubMed ID: 23392177
    [Abstract] [Full Text] [Related]

  • 24. Transforming growth factor beta-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells.
    Ohgushi M, Kuroki S, Fukamachi H, O'Reilly LA, Kuida K, Strasser A, Yonehara S.
    Mol Cell Biol; 2005 Nov 07; 25(22):10017-28. PubMed ID: 16260615
    [Abstract] [Full Text] [Related]

  • 25. Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma.
    Chen YJ, Chi CW, Su WC, Huang HL.
    Oncotarget; 2014 Jul 15; 5(13):4845-54. PubMed ID: 24947784
    [Abstract] [Full Text] [Related]

  • 26. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
    Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS, Sonenshein GE.
    Oncogene; 2003 Jan 23; 22(3):412-25. PubMed ID: 12545162
    [Abstract] [Full Text] [Related]

  • 27. Regulation of autophagy by transforming growth factor-β (TGF-β) signaling.
    Suzuki HI, Kiyono K, Miyazono K.
    Autophagy; 2010 Jul 23; 6(5):645-7. PubMed ID: 20458184
    [Abstract] [Full Text] [Related]

  • 28. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
    Yu J, Zhang L, Chen A, Xiang G, Wang Y, Wu J, Mitchelson K, Cheng J, Zhou Y.
    J Cell Physiol; 2008 May 23; 215(2):422-33. PubMed ID: 17960585
    [Abstract] [Full Text] [Related]

  • 29. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
    Mu X, Lin S, Yang J, Chen C, Chen Y, Herzig MC, Washburn K, Halff GA, Walter CA, Sun B, Sun LZ.
    PLoS One; 2013 May 23; 8(5):e63436. PubMed ID: 23704908
    [Abstract] [Full Text] [Related]

  • 30. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K, Date M, Furukawa F, Tahashi Y, Matsushita M, Sugano Y, Yamashiki N, Nakagawa T, Seki T, Nishizawa M, Fujisawa J, Inoue K.
    Hepatology; 2000 Aug 23; 32(2):218-27. PubMed ID: 10915727
    [Abstract] [Full Text] [Related]

  • 31. Dab2 inhibits the cholesterol-dependent activation of JNK by TGF-β.
    Shapira KE, Hirschhorn T, Barzilay L, Smorodinsky NI, Henis YI, Ehrlich M.
    Mol Biol Cell; 2014 May 23; 25(10):1620-8. PubMed ID: 24648493
    [Abstract] [Full Text] [Related]

  • 32. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.
    Yan X, Wu J, Jiang Q, Cheng H, Han JJ, Chen YG.
    J Mol Cell Biol; 2018 Feb 01; 10(1):48-59. PubMed ID: 29036306
    [Abstract] [Full Text] [Related]

  • 33. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition.
    Li J, Yang B, Zhou Q, Wu Y, Shang D, Guo Y, Song Z, Zheng Q, Xiong J.
    Carcinogenesis; 2013 Jun 01; 34(6):1343-51. PubMed ID: 23430956
    [Abstract] [Full Text] [Related]

  • 34. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y, Matsuzaki K, Tahashi Y, Furukawa F, Mori S, Yamagata H, Yoshida K, Matsushita M, Nishizawa M, Fujisawa J, Inoue K.
    Oncogene; 2003 Apr 17; 22(15):2309-21. PubMed ID: 12700666
    [Abstract] [Full Text] [Related]

  • 35. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells.
    Wang Y, Han C, Lu L, Magliato S, Wu T.
    Hepatology; 2013 Sep 17; 58(3):995-1010. PubMed ID: 23504944
    [Abstract] [Full Text] [Related]

  • 36. Atg7- and Keap1-dependent autophagy protects breast cancer cell lines against mitoquinone-induced oxidative stress.
    Gonzalez Y, Aryal B, Chehab L, Rao VA.
    Oncotarget; 2014 Mar 30; 5(6):1526-37. PubMed ID: 24681637
    [Abstract] [Full Text] [Related]

  • 37. Induction of autophagy in hepatocellular carcinoma cells by SB203580 requires activation of AMPK and DAPK but not p38 MAPK.
    Zhang H, Chen GG, Zhang Z, Chun S, Leung BC, Lai PB.
    Apoptosis; 2012 Apr 30; 17(4):325-34. PubMed ID: 22170404
    [Abstract] [Full Text] [Related]

  • 38. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.
    Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY, Hui B, Zhou J, Qiu SJ, Dai Z, Fan J.
    Autophagy; 2013 Dec 30; 9(12):2056-68. PubMed ID: 24157892
    [Abstract] [Full Text] [Related]

  • 39. Autophagy is required for mammary tumor recurrence by promoting dormant tumor cell survival following therapy.
    Dwyer S, Ruth J, Seidel HE, Raz AA, Chodosh LA.
    Breast Cancer Res; 2024 Oct 18; 26(1):143. PubMed ID: 39425240
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells.
    Tong Y, Huang H, Pan H.
    Biochem Biophys Res Commun; 2015 Jan 02; 456(1):86-91. PubMed ID: 25446102
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.